Growth hormone overexpression in the central nervous system results in hyperphagia-induced obesity associated with insulin resistance and dyslipidemia.
about
Ablation of PGC-1beta results in defective mitochondrial activity, thermogenesis, hepatic function, and cardiac performanceNeural growth hormone: regional regulation by estradiol and/or sex chromosome complement in male and female miceMouse model systems to study sex chromosome genes and behavior: relevance to humans.Neural growth hormone implicated in body weight sex differencesSexual dimorphism of growth hormone in the hypothalamus: regulation by estradiolHypothalamic growth hormone receptor (GHR) controls hepatic glucose production in nutrient-sensing leptin receptor (LepRb) expressing neuronsExtensive phenotypic characterization of a new transgenic mouse reveals pleiotropic perturbations in physiology due to mesenchymal hGH minigene expression.Resistance to diet-induced obesity in mice with synthetic glyoxylate shuntArginase: a critical regulator of nitric oxide synthesis and vascular function.Growth hormone modulates hypothalamic inflammation in long-lived pituitary dwarf mice.Evaluation of growth hormone (GH) action in mice: discovery of GH receptor antagonists and clinical indications.The GH/IGF-1 axis in obesity: pathophysiology and therapeutic considerations.Somatostatin Agonist Pasireotide Inhibits Exercise-Stimulated Growth in the Male Siberian Hamster (Phodopus sungorus).Free access to running wheels abolishes hyperphagia in human growth hormone transgenic rats.Growth hormone receptor deficiency results in blunted ghrelin feeding response, obesity, and hypolipidemia in mice.Growth Hormone (GH) and Gonadotropin-Releasing Hormone (GnRH) in the Central Nervous System: A Potential Neurological Combinatory Therapy?
P2860
Q27335066-9B893CFB-4797-40D6-9B8A-98DDD260B243Q30299917-38A0B248-5532-4E6F-BD94-AD5F2BE37B07Q30370628-E3D92C51-6744-42C4-A8F3-73A9CA15EB9AQ30410416-057F574A-213F-43AE-A55F-878C4D7F1A8AQ30421556-E2C00C27-DC42-4637-9E0F-836B0E3D1C35Q33600513-3B31139D-FA93-40F7-8509-70F880601694Q33729165-729C7F14-2375-4A3F-922F-F59CDAC81182Q34778767-BD4E1916-141F-498C-903C-4D927FCE197BQ35954810-599EAE65-698C-4BF0-9933-F64DC3A46077Q36410031-6880B702-C7F2-49D5-880A-A857699A01DEQ37619460-E84FF92B-0CD2-4DCF-ABEE-7BA2400DE051Q38097351-2EB34CCA-D15E-4217-9AA2-071B0AB47278Q39164141-8CA43243-0078-4FDE-997C-501C9ABB8C67Q41898347-37E10C25-0A7E-490A-A32B-3A390C36E5E8Q46713283-A4CEDB1E-4776-44DD-AD81-A7914CC8D2D9Q47837950-05824340-2DF1-4A60-948D-5C504DB4847F
P2860
Growth hormone overexpression in the central nervous system results in hyperphagia-induced obesity associated with insulin resistance and dyslipidemia.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Growth hormone overexpression ...... n resistance and dyslipidemia.
@en
Growth hormone overexpression ...... n resistance and dyslipidemia.
@nl
type
label
Growth hormone overexpression ...... n resistance and dyslipidemia.
@en
Growth hormone overexpression ...... n resistance and dyslipidemia.
@nl
prefLabel
Growth hormone overexpression ...... n resistance and dyslipidemia.
@en
Growth hormone overexpression ...... n resistance and dyslipidemia.
@nl
P2093
P50
P921
P356
P1433
P1476
Growth hormone overexpression ...... n resistance and dyslipidemia.
@en
P2093
Carl E G Bruder
Daniel Lindén
Emil Egecioglu
Frank Sundler
Jan Oscarsson
Jan Törnell
John C Waterton
Lennart Svensson
Mikael Bjursell
Mohammad Bohlooly-Y
P356
10.2337/DIABETES.54.1.51
P407
P577
2005-01-01T00:00:00Z